Papassotiriou, I.; Kapogiannatos, A.; Makatsoris, C.; Bakogeorgou, S.; Mantogiannakou, I.; Roussou, E.; Souras, G.; Liakas, D.; Sergentanis, T.N.; Gavriatopoulou, M.;
et al. Efficacy and Safety of Amivantamab in Advanced or Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review. J. Clin. Med. 2024, 13, 5489.
https://doi.org/10.3390/jcm13185489
AMA Style
Papassotiriou I, Kapogiannatos A, Makatsoris C, Bakogeorgou S, Mantogiannakou I, Roussou E, Souras G, Liakas D, Sergentanis TN, Gavriatopoulou M,
et al. Efficacy and Safety of Amivantamab in Advanced or Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review. Journal of Clinical Medicine. 2024; 13(18):5489.
https://doi.org/10.3390/jcm13185489
Chicago/Turabian Style
Papassotiriou, Ionas, Antonios Kapogiannatos, Christos Makatsoris, Sabrina Bakogeorgou, Ioanna Mantogiannakou, Emmanouela Roussou, Georgios Souras, Dimitris Liakas, Theodoros N. Sergentanis, Maria Gavriatopoulou,
and et al. 2024. "Efficacy and Safety of Amivantamab in Advanced or Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review" Journal of Clinical Medicine 13, no. 18: 5489.
https://doi.org/10.3390/jcm13185489
APA Style
Papassotiriou, I., Kapogiannatos, A., Makatsoris, C., Bakogeorgou, S., Mantogiannakou, I., Roussou, E., Souras, G., Liakas, D., Sergentanis, T. N., Gavriatopoulou, M., & Ntanasis-Stathopoulos, I.
(2024). Efficacy and Safety of Amivantamab in Advanced or Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review. Journal of Clinical Medicine, 13(18), 5489.
https://doi.org/10.3390/jcm13185489